Lifecore Biomedical, Inc. De (LFCR) Non-Current Assets (2011 - 2025)

Lifecore Biomedical's Non-Current Assets history runs 15 years deep, the most recent figure standing at $153.7 million for Q2 2025.

• In Q2 2025, Non-Current Assets fell 11.14% year-over-year to $153.7 million; the TTM figure through May 2025 stood at $653.3 million (down 3.2% YoY), while the FY2025 annual figure was $153.7 million, down 11.14% from the prior year.
• Non-Current Assets was $153.7 million for Q2 2025 at Lifecore Biomedical, roughly flat from $153.5 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $356.6 million in Q2 2021 to a low of $153.5 million in Q1 2025.
• Historically, Non-Current Assets has averaged $199.6 million across 5 years, with a median of $169.6 million in 2023.
• The sharpest annual moves came in 2021 and 2022: Non-Current Assets soared 161.44% in 2021, then slumped 55.68% in 2022.
• A 5-year view of Non-Current Assets shows it stood at $270.8 million in 2021, then slumped by 42.05% to $156.9 million in 2022, then rose by 7.78% to $169.1 million in 2023, then climbed by 2.62% to $173.5 million in 2024, then dropped by 11.45% to $153.7 million in 2025.
• The last three Non-Current Assets figures came in at $153.7 million (Q2 2025), $153.5 million (Q1 2025), and $173.5 million (Q4 2024), per Business Quant data.